PM
Prosight Management Portfolio holdings
AUM
$410M
This Quarter Return
+4.99%
1 Year Return
-14.96%
3 Year Return
+21.81%
5 Year Return
+1.17%
10 Year Return
–
AUM
$197M
AUM Growth
+$197M
(-9.8%)
Cap. Flow
-$23.6M
Cap. Flow
% of AUM
-11.98%
Top 10 Holdings %
Top 10 Hldgs %
62.37%
Holding
44
New
8
Increased
13
Reduced
17
Closed
5
Top Buys
| 1 |
Kura Oncology
KURA
|
$13.7M |
| 2 |
uniQure
QURE
|
$9.38M |
| 3 |
Q32 Bio
QTTB
|
$7.22M |
| 4 |
Bristol-Myers Squibb
BMY
|
$5.78M |
| 5 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
$5.05M |
Top Sells
| 1 |
Cigna
CI
|
$16.8M |
| 2 |
Iovance Biotherapeutics
IOVA
|
$12.7M |
| 3 |
WCG
Wellcare Health Plans, Inc.
WCG
|
$9.75M |
| 4 |
HNGR
Hanger Inc.
HNGR
|
$8.46M |
| 5 |
NVRO
NEVRO CORP.
NVRO
|
$7.63M |
Sector Composition
| 1 | Healthcare | 98.13% |
| 2 | Technology | 0.92% |
| 3 | Industrials | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Evolus
EOLS
$477M
| $1.65M | 0.83% |
+112,590
| New | +$1.65M |
|
27
Personalis
PSNL
$430M
| $1.53M | 0.77% |
+56,446
| New | +$1.53M |
|
|
SRRA
28
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $1.5M | 0.76% |
2,681,618
+223,935
| +9% | +$125K |
|
|
UROV
29
DELISTED
Urovant Sciences Ltd.
UROV
| $1.13M | 0.57% |
142,620
+42,750
| +43% | +$338K |
|
|
ARQL
30
DELISTED
Arqule Inc
ARQL
| $921K | 0.46% |
+83,675
| New | +$921K |
|
31
Tempest Therapeutics
TPST
$46.6M
| $854K | 0.43% |
73,868
-196,894
| -73% | -$2.28M |
|
|
MODV
32
DELISTED
ModivCare
MODV
| $842K | 0.42% |
14,677
-37,647
| -72% | -$2.16M |
|
33
ADMA Biologics
ADMA
$4.03B
| $719K | 0.36% |
+185,721
| New | +$719K |
|
|
NVRO
34
DELISTED
NEVRO CORP.
NVRO
| $713K | 0.36% |
11,000
-117,765
| -91% | -$7.63M |
|
35
United Therapeutics
UTHR
$17.7B
| $671K | 0.34% |
+8,600
| New | +$671K |
|
36
Cidara Therapeutics
CDTX
$1.61B
| $603K | 0.3% |
358,963
+138,699
| +63% | +$233K |
|
37
Kezar Life Sciences
KZR
$28.5M
| $264K | 0.13% |
+34,224
| New | +$264K |
|
38
Neurogene
NGNE
$284M
| $9K | ﹤0.01% |
3,637
-24,663
| -87% | -$61K |
|
39
Avalo Therapeutics
AVTX
$139M
| – | – |
-113,835
| Closed | -$665K |
|
40
Enanta Pharmaceuticals
ENTA
$189M
| – | – |
-709
| Closed | -$68K |
|
41
Exact Sciences
EXAS
$9.33B
| – | – |
0
| – | – |
|
42
MacroGenics
MGNX
$121M
| – | – |
-107,560
| Closed | -$1.93M |
|
43
MeiraGTx Holdings
MGTX
$590M
| – | – |
-91,317
| Closed | -$1.57M |
|
|
WAGE
44
DELISTED
WageWorks, Inc.
WAGE
| – | – |
-115,926
| Closed | -$4.38M |
|